Skip to Main Content
Back to News

Intuitive Surgical Stock (ISRG) Opinions on Recent Performance and Innovation

None

Recent discussions on X about Intuitive Surgical (ISRG) have centered around the company's strong performance and innovative strides in robotic-assisted surgery. Many users have highlighted the stock's recent uptick, with some noting a price increase to around $447 and expressing optimism about future growth tied to the adoption of the da Vinci 5 system. The chatter also reflects confidence in the company’s ability to maintain its leadership in the medical technology space.

However, not all sentiments are uniformly positive, as some discussions point to potential challenges like market competition and external economic pressures such as tariffs. A few voices on X have raised questions about whether the stock can sustain its long-term growth trajectory amidst these hurdles. Overall, the tone on the platform remains largely constructive, with a focus on the company's strategic advancements.

Note: This discussion summary was generated from an AI condensation of post data.

Intuitive Surgical Congressional Stock Trading

Members of Congress have traded $ISRG stock 10 times in the past 6 months. Of those trades, 3 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $ISRG stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Intuitive Surgical Insider Trading Activity

ISRG Insider Trades

Intuitive Surgical insiders have traded $ISRG stock on the open market 32 times in the past 6 months. Of those trades, 0 have been purchases and 32 have been sales.

Here’s a breakdown of recent trading of $ISRG stock by insiders over the last 6 months:

  • GARY S GUTHART (Executive Chair of the Board o) has made 0 purchases and 4 sales selling 40,053 shares for an estimated $19,194,645.
  • AMY L LADD has made 0 purchases and 7 sales selling 9,447 shares for an estimated $4,742,258.
  • MYRIAM CURET (EVP & Chief Medical Officer) has made 0 purchases and 2 sales selling 8,500 shares for an estimated $4,268,880.
  • JAMI K NACHTSHEIM sold 2,400 shares for an estimated $1,248,000
  • GARY LOEB (EVP & Chief Legal and Complian) sold 1,700 shares for an estimated $872,405
  • MARK BROSIUS (SVP & Chief Mfg and Supply Cha) has made 0 purchases and 10 sales selling 1,184 shares for an estimated $657,803.
  • ROBERT DESANTIS (EVP & Chief Strategy & Corp Op) has made 0 purchases and 6 sales selling 990 shares for an estimated $508,508.
  • JAMIE SAMATH (See Remarks) sold 915 shares for an estimated $483,074

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Intuitive Surgical Hedge Fund Activity

We have seen 1,183 institutional investors add shares of Intuitive Surgical stock to their portfolio, and 805 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • GAMMA INVESTING LLC removed 3,021,842 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $1,642,099,161
  • WCM INVESTMENT MANAGEMENT, LLC removed 1,189,761 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $646,528,025
  • FMR LLC removed 1,072,651 shares (-11.0%) from their portfolio in Q2 2025, for an estimated $582,889,279
  • VICTORY CAPITAL MANAGEMENT INC added 943,348 shares (+219.1%) to their portfolio in Q2 2025, for an estimated $512,624,736
  • JPMORGAN CHASE & CO removed 896,971 shares (-10.5%) from their portfolio in Q2 2025, for an estimated $487,423,011
  • AMUNDI removed 815,166 shares (-24.7%) from their portfolio in Q2 2025, for an estimated $442,969,356
  • VANGUARD GROUP INC added 670,302 shares (+2.1%) to their portfolio in Q2 2025, for an estimated $364,248,809

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Intuitive Surgical Government Contracts

We have seen $22,007,320 of award payments to $ISRG over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Intuitive Surgical Analyst Ratings

Wall Street analysts have issued reports on $ISRG in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 10/01/2025
  • RBC Capital issued a "Outperform" rating on 08/19/2025
  • Piper Sandler issued a "Overweight" rating on 07/23/2025
  • Wells Fargo issued a "Overweight" rating on 07/23/2025
  • Deutsche Bank issued a "Sell" rating on 06/09/2025
  • Citigroup issued a "Buy" rating on 05/22/2025
  • Barclays issued a "Overweight" rating on 04/24/2025

To track analyst ratings and price targets for Intuitive Surgical, check out Quiver Quantitative's $ISRG forecast page.

Intuitive Surgical Price Targets

Multiple analysts have issued price targets for $ISRG recently. We have seen 11 analysts offer price targets for $ISRG in the last 6 months, with a median target of $595.0.

Here are some recent targets:

  • Ryan Zimmerman from BTIG set a target price of $571.0 on 10/01/2025
  • Shagun Singh from RBC Capital set a target price of $615.0 on 08/19/2025
  • Danielle Antalffy from UBS set a target price of $585.0 on 07/23/2025
  • Larry Biegelsen from Wells Fargo set a target price of $599.0 on 07/23/2025
  • Richard Newitter from Truist Securities set a target price of $600.0 on 07/23/2025
  • Adam Maeder from Piper Sandler set a target price of $595.0 on 07/23/2025
  • Vijay Kumar from Evercore ISI Group set a target price of $550.0 on 07/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles